Evidence map›Paper›PMID 34458775›Full record

ReviewRSC chemical biology2021

The chemical biology of coronavirus host-cell interactions.

Suprama Datta, Erik C Hett, Kalpit A Vora, Daria J Hazuda, Rob C Oslund, Olugbeminiyi O Fadeyi, Andrew Emili

Abstract readReview
In one paragraph

Review in RSC chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. COVID-19: Vaccines and therapeutics.Bioorganic & medicinal chemistry letters · 2022
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Suprama DattaCenter for Network Systems Biology, Department of Biochemistry, Boston University School of Medicine Boston MA USA aemili@bu.edu.
Erik C HettExploratory Science Center, Merck & Co., Inc. Cambridge Massachusetts USA rob.oslund@merck.com olugbeminiyi.fadeyi@merck.com.
Kalpit A VoraInfectious Diseases and Vaccine Research, Merck & Co., Inc. West Point Pennsylvania USA.
Daria J HazudaExploratory Science Center, Merck & Co., Inc. Cambridge Massachusetts USA rob.oslund@merck.com olugbeminiyi.fadeyi@merck.com.
Rob C OslundExploratory Science Center, Merck & Co., Inc. Cambridge Massachusetts USA rob.oslund@merck.com olugbeminiyi.fadeyi@merck.com.ORCID https://orcid.org/0000-0002-2920-9532
Olugbeminiyi O FadeyiExploratory Science Center, Merck & Co., Inc. Cambridge Massachusetts USA rob.oslund@merck.com olugbeminiyi.fadeyi@merck.com.ORCID https://orcid.org/0000-0002-5525-1304
Andrew EmiliCenter for Network Systems Biology, Department of Biochemistry, Boston University School of Medicine Boston MA USA aemili@bu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the current coronavirus disease 2019 (COVID-19) pandemic that has led to a global economic disruption and collapse. With several ongoing efforts to develop vaccines and treatments for COVID-19, understanding the molecular interaction between the coronavirus, host cells, and the immune system is critical for effective therapeutic interventions. Greater insight into these mechanisms will require the contribution and combination of multiple scientific disciplines including the techniques and strategies that have been successfully deployed by chemical biology to tease apart complex biological pathways. We highlight in this review well-established strategies and methods to study coronavirus-host biophysical interactions and discuss the impact chemical biology will have on understanding these interactions at the molecular level.

Identifiers

PMID34458775
PMCPMC8340996

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.